Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 492187038 series 3484302
Content provided by HemaSphere Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by HemaSphere Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of the HemaSphere podcast, host Charles de Bock and guest Tim Mocking, PhD, discuss the role of machine learning in the assessment of measurable residual disease (MRD) in acute myeloid leukemia (AML). They explore the challenges of MRD detection, the potential of machine learning to improve accuracy and efficiency, and the importance of understanding the human element in computational methods. The conversation also touches on the adoption of AI in hematology, the future of flow cytometry, and the implications of new technologies for patient care.
Episode 3.3 - Machine learning for AML-MRD is based on the recently published Review Article "Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia”, is on our website, all major podcast platforms, and YouTube. Listen and enjoy casual, insightful discussions about #hematology research.
You can find the referenced article, in full and open access, here on the HemaSphere website.
19 episodes
